Costs and Consequences Associated With Misdiagnosed Lower Extremity Cellulitis
- PMID: 27806170
- DOI: 10.1001/jamadermatol.2016.3816
Costs and Consequences Associated With Misdiagnosed Lower Extremity Cellulitis
Abstract
Importance: Inflammatory dermatoses of the lower extremity are often misdiagnosed as cellulitis (aka "pseudocellulitis") and treated with antibiotics and/or hospitalization. There is limited data on the cost and complications from misdiagnosed cellulitis.
Objective: To characterize the national health care burden of misdiagnosed cellulitis in patients admitted for treatment of lower extremity cellulitis.
Design, setting, and participants: Cross-sectional study using patients admitted from the emergency department (ED) of a large urban hospital with a diagnosis of lower extremity cellulitis between June 2010 and December 2012. Patients who were discharged with a diagnosis of cellulitis were categorized as having cellulitis, while those who were given an alternative diagnosis during the hospital course, on discharge, or within 30 days of discharge were considered to have pseudocellulitis. A literature review was conducted for calculation of large-scale costs and complication rates. We obtained national cost figures from the Medical Expenditure Panel Survey (MEPS), provided by the Agency for Healthcare Research and Quality (AHRQ) for 2010 to calculate the hospitalization costs per year attributed to misdiagnosed lower extremity pseudocellulitis.
Exposures: The exposed group was composed of patients who presented to and were admitted from the ED with a diagnosis of lower extremity cellulitis.
Main outcomes and measures: Patient characteristics, hospital course, and complications during and after hospitalization were reviewed for each patient, and estimates of annual costs of misdiagnosed cellulitis in the United States.
Results: Of 259 patients, 79 (30.5%) were misdiagnosed with cellulitis, and 52 of these misdiagnosed patients were admitted primarily for the treatment of cellulitis. Forty-four of the 52 (84.6%) did not require hospitalization based on ultimate diagnosis, and 48 (92.3%) received unnecessary antibiotics. We estimate cellulitis misdiagnosis leads to 50 000 to 130 000 unnecessary hospitalizations and $195 million to $515 million in avoidable health care spending. Unnecessary antibiotics and hospitalization for misdiagnosed cellulitis are projected to cause more than 9000 nosocomial infections, 1000 to 5000 Clostridium difficile infections, and 2 to 6 cases of anaphylaxis annually.
Conclusions and relevance: Misdiagnosis of lower extremity cellulitis is common and may lead to unnecessary patient morbidity and considerable health care spending.
Comment in
-
Cellulitis: Commonly Misdiagnosed or Just Misunderstood?JAMA. 2017 Feb 21;317(7):760-761. doi: 10.1001/jama.2016.15921. JAMA. 2017. PMID: 28241341 No abstract available.
Similar articles
-
Outcomes of Early Dermatology Consultation for Inpatients Diagnosed With Cellulitis.JAMA Dermatol. 2018 May 1;154(5):537-543. doi: 10.1001/jamadermatol.2017.6197. JAMA Dermatol. 2018. PMID: 29453874 Free PMC article.
-
A predictive model for diagnosis of lower extremity cellulitis: A cross-sectional study.J Am Acad Dermatol. 2017 Apr;76(4):618-625.e2. doi: 10.1016/j.jaad.2016.12.044. Epub 2017 Feb 16. J Am Acad Dermatol. 2017. PMID: 28215446
-
Validation of Thermal Imaging and the ALT-70 Prediction Model to Differentiate Cellulitis From Pseudocellulitis.JAMA Dermatol. 2024 May 1;160(5):511-517. doi: 10.1001/jamadermatol.2024.0091. JAMA Dermatol. 2024. PMID: 38536160
-
Distinguishing Cellulitis from Its Noninfectious Mimics: Approach to the Red Leg.Infect Dis Clin North Am. 2021 Mar;35(1):61-79. doi: 10.1016/j.idc.2020.10.001. Epub 2020 Dec 7. Infect Dis Clin North Am. 2021. PMID: 33303330 Review.
-
Prevalence of misdiagnosis of cellulitis: A systematic review and meta-analysis.J Hosp Med. 2023 Mar;18(3):254-261. doi: 10.1002/jhm.12977. Epub 2022 Oct 3. J Hosp Med. 2023. PMID: 36189619 Review.
Cited by
-
Intravenous Versus Oral Omadacycline or Linezolid for Acute Bacterial Skin and Skin Infections: A post hoc Analysis of the OASIS Trials.Infect Dis Ther. 2024 Dec;13(12):2637-2648. doi: 10.1007/s40121-024-01057-3. Epub 2024 Oct 26. Infect Dis Ther. 2024. PMID: 39461915 Free PMC article.
-
Mind the gap: the adjunctive role of anti-inflammatories for treating cellulitis.CJEM. 2024 Jul;26(7):445-446. doi: 10.1007/s43678-024-00724-1. CJEM. 2024. PMID: 38960971 No abstract available.
-
Pseudocellulitis in oncology patients: A single institutional retrospective analysis investigating the clinical presentation, therapeutic response, and implications for cancer therapy.JAAD Int. 2023 Jun 24;12:186-188. doi: 10.1016/j.jdin.2023.04.016. eCollection 2023 Sep. JAAD Int. 2023. PMID: 37560470 Free PMC article. No abstract available.
-
The impact of a point-of-care visual clinical decision support tool on admissions for cellulitis in the University of Maryland medical system.J Am Coll Emerg Physicians Open. 2023 Jun 8;4(3):e12969. doi: 10.1002/emp2.12969. eCollection 2023 Jun. J Am Coll Emerg Physicians Open. 2023. PMID: 37304858 Free PMC article.
-
Misdiagnosis of Uncomplicated Cellulitis: a Systematic Review and Meta-analysis.J Gen Intern Med. 2023 Aug;38(10):2396-2404. doi: 10.1007/s11606-023-08229-w. Epub 2023 May 25. J Gen Intern Med. 2023. PMID: 37231210 Free PMC article.
LinkOut - more resources
Full Text Sources
Other Literature Sources
